Perforin gene mutations in patients with acquired aplastic anemia

Blood

Volumn 109, Issue 12, 2007, Pages 5234-5237

  Solomou, Elena E ^a,c   Gibellini, Federica ^a   Stewart, Brian ^b   Malide, Daniela ^a   Berg, Maria ^a   Visconte, Valeria ^a   Green, Spencer ^a   Childs, Richard ^a   Chanock, Stephen J ^b   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORIN;

APLASTIC ANEMIA; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROPHAGOCYTOSIS; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 34250028444     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-12-063495     Document Type: Article

References (25)

1. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509-2519.
2. Solomou EE, Keyvanfar K, Young NS. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood. 2006;107:3983-3991.
3. Gascon P, Zoumbos N, Young N. Analysis of natural killer cells in patients with aplastic anemia. Blood. 1986;67:1349-1355.
4. Stepp SE, Mathew PA, Bennett M, de Saint BG, Kumar V. Perforin: more than just an effector molecule. Immunol Today. 2000;21:254-256.
5. Ashton-Rickardt PG. The granule pathway of programmed cell death. Crit Rev Immunol. 2005;25:161-182.
6. Glimcher LH, Townsend MJ, Sullivan BM, Lord GM. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat Rev Immunol. 2004;4:900-911.
7. Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005;:82-88.
8. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev. 2004;3:69-75.
9. Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol. 2006;6:940-952.
10. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res. 2006;34:D617-D621.
11. Cann HM, de Toma C, Cazes L et al. A human genome diversity cell line panel [letter]. Science. 2002;296:261-262.
12. Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med. 2005;352:1413-1424.
13. Stepp SE, Dufourcq-Lagelouse R, Le DF et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959.
14. Kogawa K, Lee SM, Villanueva J, et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002;99:61-66.
15. Katano H, Cohen JI. Perforin and lymphohistiocytic proliferative disorders. Br J Haematol. 2005;128:739-750.
16. Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS. Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med. 1985;312:257-265.
17. Molleran LS, Villanueva J, Sumegi J, et al. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet. 2004;41:137-144.
18. Trambas C, Gallo F, Pende D, et al. A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood. 2005;106:932-937.
19. Zur Stadt U, Beutel K, Weber B, et al. A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype [letter]. Blood. 2004;104:1909.
20. Voskoboinik I, Thia MC, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood. 2005;105:4700-4706.
21. Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100:2266-2267.
22. Risma KA, Frayer RW, Filipovich AH, Sumegi J. Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest. 2006;116:182-192.
23. O'Brien MM, Lee-Kim Y, George TI, et al. Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. Prepublished on July 19, 2006, as DOI 10.1002/pbc.20950.
24. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6:601-608.
25. Marmont AM, Bacigalupo A, Van Lint MT, et al. Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin. Prog Clin Biol Res. 1984;148:271-287.